Sunniva Inc. (OTCPK: SNNV.F)
Health Care · Pharmaceuticals · CA
$0.00
— today · 0.0% 1Y
Sunniva Inc. (OTCPK: SNNV.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $796.00.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores Sunniva Inc. across four factors: quality 21/100, value 51/100. Its strongest factor is value.
SNNV.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $796.00
- Revenue (TTM)
- $26.47M
- P/E
- —
- EPS
- -1.31
- Dividend yield
- —
- Beta (5Y)
- -87.02
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 795.75M
- Employees
- —
- Next earnings
- —
About Sunniva Inc.
Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.
- ISIN
- CA86745H1010
- Founded
- 2014
- Listed since
- Jan 10, 2018
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,213.74 | -1.61% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.87 | -0.83% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $154.50 | -1.25% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.90 | -1.04% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.60 | -1.73% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.29 | -0.98% |
Figures last refreshed Aug 18, 2026.